Phase I Clinical and Pharmacokinetic Study of Oral Sapacitabine in Patients With Acute Leukemia and Myelodysplastic Syndrome

PURPOSE: Sapacitabine is an oral deoxycytidine nucleoside analog with a unique mechanism of action that is different from cytarabine. PATIENTS AND METHODS: To define the dose-limiting toxicities (DLT) and maximum-tolerated dose (MTD) of sapacitabine given orally twice daily for 7 days every 3 to 4 w...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Kantarjian, Hagop, Garcia-Manero, Guillermo, O'Brien, Susan, Faderl, Stefan, Ravandi, Farhad, Westwood, Robert, Green, Simon R., Chiao, Judy H., Boone, Patricia A., Cortes, Jorge, Plunkett, William
格式: Artigo
語言:Inglês
出版: American Society of Clinical Oncology 2010
主題:
Original Reports
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3340938/
https://ncbi.nlm.nih.gov/pubmed/19933907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.0209
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍